The effect of 1% apraclonidine on visual field parameters in patients with glaucoma and ocular hypertension

Annals of Ophthalmology - Glaucoma

Volumn 30, Issue 1, 1998, Pages 41-45

  Mastropasqua, Leonardo ^a,b   Ciancaglini, Marco ^b   Carpineto, Paolo ^a   Verdesca, Gianmaria ^b   Ciafre, Michele ^b   Costagliola, Ciro ^a  

^a Institute of Ophthalmology ^*

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APRACLONIDINE;

ADULT; AQUEOUS HUMOR FLOW; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR AUTOREGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLAUCOMA; HEMODYNAMIC PARAMETERS; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR HYPERTENSION; MALE; OPTIC NERVE ATROPHY; PERFUSION PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASOCONSTRICTION; VISUAL FIELD DEFECT;

EID: 0031932049     PISSN: 10794794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cavero I, Depoortere H, Lefevre-Borg F. Pharmacological studies on para- aminoclonidine. Br J Ophthalmol. 1980;69:295-296.
2. Jampel HD, Robin AL, Quigley HA, Pollack IP. Apraclonidine Hidrochloride: a one week dose response study. Arch Ophthalmol. 1988;106:1069-1073.
3. Abrams DA, Robin AL, Pollack IP, de Faller JM, DeSantis L. The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine monohydrochloride) in normal volunteers. Arch Ophthalmol. 1987;105:1205-1207.
4. Hernandez Y, Hernandez H, Cervantes, R, et al. Cardiovascular effects of topical glaucoma therapies in normal subjects. J Toxicol Cut Ocul Toxicol. 1983;2:99-106.
5. Chein D, Tang-lieu DD, Gluchowsky C. Corneal and conjunctival/scleral absorption of alpha2-adrenergic agents in rabbit eyes. Invest Ophthalmol Vis Sci. 1990;31(suppl):403.
6. Toris CB, Tafoya ME, Camras CB, Yablonsky ME. Effects of apraclonidine on aquoeus humor dinamics in human eyes. Ophthalmology. 1995;102:456-461.
7. Serdahl CL, Galustian J, Lewis RA. The effects of apraclonidine on conjuctival oxygen tension. Arch Ophthalmol. 1989;107:1777-1779.
8. Mansberger S, Harris A, Caldemeyer K, Kopecky K, Azuara A, Shoemaker JA, Bohnke K. Acute effect of topical apraclonidine on perimacular and orbital hemodynamic. ARVO. Sarasota, Florida, 1992;33:1078.
9. Best SJ, Katz LJ, Sergott KC. Color doppler imaging of apraclonidine induced changes in periocular blood flow. ARVO. Sarasota, Florida, 1992;33:1078.
10. Hicks El, Fornili RM, Allen RC. The effect of 1% apraclonidine on visual field of normal volunteers. ARVO. Sarasota, Florida, 1990; 431.
11. Johnson, CA. Standardizing the measurement of visual field for clinical research. Ophthalmology. 1996;103:186-189.
12. Alm A. Ocular circulation. In: Hart WM, ed. Adler's Phisiology of the Eye. 9th ed. St. Louis, Mo: CV Mosby. 1992:198-227.
13. Hayreh SS. Blood supply of the anterior optic nerve. In: Ritch R, Shiels MB, Krupin T, eds. The Glaucomas. St. Louis, Mo: CV Mosby. 1989:133-161.
14. 2 binding sites are present in bovine retinal blood vessels. Invest Ophthalmol Vis Sci. 1987;28:1741-1745.
15. Fahrenbach WH, Bacon DR, Van Buskirk EM. Vasoactive drug effect on the uveal vasculature of the rabbit: a corrosion casting study. Invest Ophthalmol Vis Sci. 1989;30:100-105.